Bottom line
GDOC vs PHSYX: the short answer
GDOC (Goldman Sachs Future Health Care Equity ETF) and PHSYX (Putnam Global Health Care Fund) share a meaningful slice of their top holdings — about 54% by weight.
But PHSYX is far broader, holding 115 positions to 42 for GDOC, so beyond the top names it adds exposure GDOC doesn't have.
GDOC is cheaper at 0.75% vs 0.79% — a difference of $4.00 a year per $10,000 invested.
Over one year, PHSYX returned +1.5% vs −1.6% for GDOC.
Updated Nov 19, 2026
GDOC vs PHSYX side by side
| GDOC | PHSYX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Goldman Sachs | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.75% | 0.79% |
| Annual cost per $10k | $75 | $79 |
| 10-yr cost on $10k (prospectus) | $930 | $978 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −1.6% | +1.5% |
| 5-yr return (annualized) | — | +8.1% |
| 10-yr return (annualized) | — | +7.8% |
| Best quarter | +10.7% | — |
| Worst quarter | −13.5% | — |
| Net assets (fund) | $20.1M | $1.5B |
| Number of holdings | 42 | 115 |
| Portfolio turnover | 46% | 67% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of GDOC's top 25 holdings also appear in PHSYX's top 25.
| Holding | GDOC | PHSYX |
|---|---|---|
| Eli Lilly & Company | 13.28% | 13.15% |
| Johnson & Johnson | 8.07% | 8.46% |
| Merck & Company Inc | 5.94% | 4.88% |
| Astrazeneca Plc | 4.84% | 4.67% |
| Thermo Fisher Scientific Inc | 4.52% | 4.50% |
| Intuitive Surgical Inc | 3.90% | 4.04% |
| Boston Scientific Corp | 3.78% | 1.80% |
| Hoya Corp | 3.53% | 1.52% |
| Edwards Lifesciences Corp | 2.98% | 2.80% |
| Dexcom Inc | 2.79% | 1.64% |
| Vertex Pharmaceuticals Inc | 1.48% | 1.97% |
Source: SEC Form N-PORT
GDOC top 10
- Eli Lilly & Company — 13.28%
- Johnson & Johnson — 8.07%
- Merck & Company Inc — 5.94%
- Guardant Health Inc — 5.34%
- Astrazeneca Plc — 4.84%
- Thermo Fisher Scientific Inc — 4.52%
- Argenx Se — 4.07%
- Intuitive Surgical Inc — 3.90%
- Boston Scientific Corp — 3.78%
- Hoya Corp — 3.53%
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FAQ
What is the difference between GDOC and PHSYX?
Which is cheaper, GDOC or PHSYX?
Should I own both GDOC and PHSYX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.